Drug Profile


Alternative Names: OR 1364

Latest Information Update: 01 Dec 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Orion
  • Class Anti-inflammatories; Cytoprotectives; Small molecules
  • Mechanism of Action Antioxidants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Crohn's disease

Most Recent Events

  • 29 Sep 2000 No-Development-Reported for Crohn's disease in Finland (Rectal)
  • 24 Feb 1998 Suspended-I for Crohn's disease in Finland (Rectal)
  • 10 May 1996 Phase-I clinical trials for Crohn's disease in Finland (Rectal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top